Biochemical aspects of Parkinson's disease
Biochemical aspects of Parkinson's disease
O. Hornykiewicz
1998 · DOI: 10.1212/WNL.51.2_Suppl_2.S2
Neurology · 588 Citations
TLDR
The view is advanced that endogenous, genetically based(excessive) formation, or accumulation, of toxic DA transporter substrates, such as isoquinoline or β-carboline derivatives, may in fact represent the primary cause of substantia nigra cell degeneration in patients with PD.
